The phosphoinositide 3-kinase [PI(3)K] pathway is a key signaling pathway important for replication of mammalian cells. In this study, we examined the role of PI(3)K in smooth muscle cell (SMC) replication after balloon catheter injury of rat carotid arteries. Protein kinase B (PKB), a downstream target of PI(3)K, was phosphorylated at 30 and 60 minutes after injury and to a lesser degree after 6 hours and 1 and 2 days but not after 7 days. Wortmannin (10 g per rat), a PI(3)K inhibitor, given to rats 60 and 5 minutes before and 11 hours after balloon injury, reduced the levels of phosphorylated PKB. SMC replication quantified between 24 to 48 hours was significantly reduced compared with control replication, as were the levels of cyclin D 1 . Wortmannin was also administered to rats between days 7 and 8 and between days 7 and 9 after balloon catheter injury. A reduction in levels of phosphorylated PKB was detected, but no decrease in the replication of intimal SMCs was observed in either experiment. These data demonstrate that the PI(3)K signal transduction pathway plays an important role in medial but not intimal SMC replication. (Arterioscler Thromb
B alloon injury to the rat carotid artery initiates smooth muscle cell (SMC) replication in a predictable manner. Our previous data suggest that the replication of intimal and medial cells is controlled by different mechanisms. For example, the extracellular signal-regulated kinase (ERK)1/2 cascade is involved in the early proliferative response of the artery after mechanical injury, inasmuch as PD98095, a mitogen-activated protein kinase kinase (MEK)1 inhibitor, significantly blocked ERK1/2 phosphorylation and SMC replication 48 hours after injury. In contrast, the MEK1 inhibitor was not able to block intimal SMC replication after 7 days. 1 These data have led us to suggest that other signaling pathways may be important for intimal cell replication.
Phosphoinositide 3-kinase [PI(3)K] is activated by many growth factors, and there is good evidence that this pathway is involved in the entry of cells into S phase. [2] [3] [4] Activation of PI(3)K leads to the generation of phosphatidylinositol 3,4diphosphate and phosphatidylinositol 3,4,5-triphosphate in the cell membrane. These phospholipids form a binding site for proteins with a pleckstrin homology domain, such as protein kinase B (PKB), and in doing so a cryptic phosphorylation site is exposed. These sites are then phosphorylated by phosphoinositide-dependent kinases (PDKs), thus leading to their activation. Once activated, PKB phosphorylates several substrates, including glycogen synthase kinase-3␤ 5 and glucose transporter 4. 6 PKB is also known to be involved in regulating cell survival and cell replication. [7] [8] [9] [10] In a previous study, we noted an increase in p70s6k activity in rat arteries after balloon injury, which suggested that the PI(3)K signal transduction pathway may be involved in controlling SMC replication. 1 The purpose of the present study was to determine whether the PI(3)K pathway is activated after balloon injury and whether this pathway is necessary for acute and late SMC replication. Our studies show that activation of PI(3)K is critical for the initial medial cell replication but that inhibition of PI(3)K does not affect the replication of intimal SMCs between 7 and 9 days after injury.
Methods

Inhibition of Medial PI(3)K Activity
Male Sprague-Dawley rats (B&K Universal, Kent, Wash) aged 3 to 4 months were used in all experiments, and all surgery was performed with the use of general anesthesia with an intraperitoneal injection of xylazine (Phoenix Pharmaceutical Inc) and ketamine (Phoenix Pharmaceutical Inc). Carotid injury was induced as previously described. 11 Wortmannin (Sigma Chemical Co) was dissolved in 4.8% dimethyl sulfoxide to a final concentration of 2.5, 5, or 10 g per 500 L. To confirm the ability of wortmannin to inhibit PI(3)K, animals received 2 intravenous injections of wortmannin (2.5, 5, or 10 g) or vehicle (4.8% dimethyl sulfoxide) at 60 minutes and 5 minutes before injury. Rats were then euthanized 30 minutes after injury, and phosphorylated (phospho)-PKB was measured by Western blot.
To investigate the effects of wortmannin on PKB phosphorylation, animals were given injections of 10 g wortmannin and euthanized at 5 and 30 minutes and 1 and 6 hours after injury. To test the effects on medial SMC proliferation, animals received injections 60 minutes and 5 minutes before injury with an additional injection 11 hours after injury; for intimal SMC proliferation, animals received 2 injections 1 hour apart on day 7 and a further injection 11 hours later. Animals were euthanized at 48 hours for medial cell replication and 8 days for intimal cell replication. The study on intimal SMC replication was repeated, and animals were given 2 additional wortmannin injections 12 hours apart on day 8 and were killed on day 9.
Wortmannin was also administered intra-arterially to the left carotid artery. The common carotid and external carotid arteries were exposed, the proximal common carotid artery was clamped with a vessel clip, and a PE-10 tube (Clay Adams) was introduced into the common carotid artery through the external carotid artery. After a flushing with Ringer's solution, 200 L wortmannin solution (100 nmol/L wortmannin and 1% dimethyl sulfoxide in Ringer's solution) was gently infused into the common carotid artery. The distal part of common carotid artery was then clamped, and the common carotid artery was left for 1 hour. After these clamps were removed, the carotid artery was injured with a balloon catheter.
Quantification of Cell Proliferation
Arterial SMC proliferation was evaluated by bromodeoxyuridine (BrdU) labeling as previously described. 1 Proliferation was measured by calculating the BrdU index as follows: (labeled nuclei)/ (total nuclei). At least 4 sections were counted from each of 5 animals. Significance between the average of the 2 groups was calculated by Student t test.
Western Blot Analysis
For Western blot analysis, a minimum of 3 carotid arteries were pooled in each group. Tissue samples were ground to a fine powder under liquid nitrogen and prepared as previously described. 1 Equal amounts of protein were run out on a 10% SDS-polyacrylamide gel and transferred to nitrocellulose. Nonspecific binding was blocked with 5% nonfat dry milk for 1 hour. The blots were incubated with anti-ERK (New England Biolabs), Akt(PKB) (New England Biolabs), phospho-ERK1/2 (Thr202/Tyr204, New England Biolabs), phospho-Akt(PKB) (Ser473, New England BioLabs), cleaved caspase-3 antibodies (New England BioLabs), and cyclin D (Upstate Biotechnology) for 1 hour. Horseradish peroxidase-labeled IgG secondary antibodies (Amersham) was used in conjunction with an enhanced chemiluminescence kit (Amersham) to visualize the bands. An identical blot was incubated with normal IgG as a control. Blots were washed 3 times with TBS-T (25 mmol/L Tris [pH 7.6], 150 mmol/L NaCl, and 0.1% Tween 20) between incubations. All incubations were carried out with agitation at room temperature in TBS-T containing 2.5% nonfat dry milk. Each gel was repeated at least twice, and similar results were obtained. Gels composed of 3 pooled carotids for each time point are presented. For quantification, images were analyzed by use of NIH Image software.
Results
PI(3)K Signaling Pathway Is Activated After Balloon Injury
Activation of the PI(3)K pathway was assessed by measuring the phosphorylation of a downstream target, PKB. Balloon injury of rat arteries stimulated a marked increase in PKB phosphorylation after 30 and 60 minutes, with a smaller increase still observed after 1 and 2 days. No PKB phosphorylation was detected 7 days after injury ( Figure 1 ).
Wortmannin Suppresses PKB Phosphorylation in Injured Arteries
To document the importance of PI(3)K for SMC replication, wortmannin (100 nmol/L) was infused into an isolated segment of the carotid artery for 60 minutes before balloon catheter injury; in this way, the drug was limited to the artery. The addition of wortmannin in this manner caused a signif-icant decrease in medial SMC replication, 22.5Ϯ3.4% versus 7.2Ϯ2.8% (PϽ0.0001) at 48 hours after balloon injury, and significantly blocked PKB phosphorylation (data not shown).
Local administration of wortmannin to replicating intimal SMCs (ie, after 7 days) required additional surgery to reexpose the artery, which increased phosphorylation of PKB and ERK1/2. Therefore, we decided to administer wortmannin by intravenous injections at 60 and 5 minutes before balloon injury. Initially, we measured the effect of differing concentrations of wortmannin by measuring any decrease in PKB. A dose of 10 g, but not 2.5 or 5 g, suppressed the levels of phospho-PKB as early as 5 minutes, which remained suppressed for at least 6 hours after balloon catheter injury ( Figure 2 ). By 12 hours, the levels of phospho-PKB were again similar to control, and so another injection (10 g per rat) was given 11 hours after balloon injury. This again suppressed phosphorylation of PKB (data not shown). In all future studies, therefore, 3 doses of wortmannin (10 g per rat) were given 60 and 5 minutes before balloon injury and a further 11 hours after surgery. Wortmannin given in this Effect of wortmannin (W, 2 times at 10 g IV per rat) or vehicle alone (V) on PKB phosphorylation 6 hours after balloon injury of carotid artery. Wortmannin was given 5 and 60 minutes before injury. Carotid lysates were immunoblotted with antibody to phospho-PKB, and images were analyzed with NIH image software. Values show fold increase relative to controls. Samples were also stained with an antibody to ERK1/2. Control animals (C) were not subjected to injury. manner did not decrease phosphorylation of ERK1/2 at any of the times studied (data not shown).
PI(3)K Inhibition Blocks Cyclin D 1 Expression and SMC Replication
The PI(3)K pathway is thought to permit the entry of cells into S phase through the interaction on downstream targets of the cell cycle and, in particular, cyclin D 1 . At 36 and 48 hours, wortmannin (3 times at 10 g per rat ) not only blocked PKB phosphorylation but also inhibited the steady-state expression of cyclin D 1 after injury ( Figure 3 ). Treatment with wortmannin also significantly inhibited SMC replication 24 to 48 hours after balloon injury ( Figure 4 ). Histological examination of these arteries showed the presence of replicating SMCs in the media (brown nuclear stain) and revealed that zones close to the lumen were often devoid of SMCs (see arrows). Quantification of the number of SMCs in these arteries showed a small but significant decrease in the wortmannin-treated animals ( Figure 4B ).
This reduction in cell number may have been caused by an increase in programmed cell death. Therefore, we evaluated apoptosis by measuring the cleavage of caspase-3 in the extracts of these injured arteries. Up to 2 days after balloon injury, no cleaved caspase-3 was detected, but an increase was noted in injured arteries after 7 days (data not shown). This study was repeated with the use of arteries from wortmannin-treated rats. No cleavage of caspase-3 was noted up to 2 days after injury, and at 7 days, no further increase in the levels of cleaved caspase-3 was noted (data not shown). Therefore, the loss of cells from the wortmannin-treated arteries does not appear to be associated with an increase in apoptosis.
Inhibition of PI(3)K Does Not Block Injury-Induced Intimal Cell Replication
The next experiments examined the effect of wortmannin on intimal cell replication. First, we ensured that wortmannin could suppress PI(3)K activity in these arteries. Phospho-PKB levels 7 days after injury are very low and are approximately equivalent to the levels detected in uninjured arteries (Figure 1 ). To visualize PKB phosphorylation in these sam- Figure 5 . Effect of wortmannin (W) on phosphorylation of PKB in arteries subjected to balloon catheter injury 7 days previously. Wortmannin (10 g IV per rat) or vehicle (V) was given at the start of day 7, followed by a second dose 60 minutes later. A third dose was given 12 hours after the start of wortmannin administration. Arteries were removed 30 minutes and 6 and 12 hours after wortmannin treatment. In a separate gel, phospho-PKB levels were quantified in arteries after 24 hours (3 times at 10 g per rat) and after 48 hours (5 times at 10 g per rat). Carotid lysates were immunoblotted with antibody to phospho-PKB, and images were analyzed with NIH image software. Values show fold increase relative to control. Similar samples were also blotted with antibody to total PKB. Control animals (C) were subjected to balloon injury 7 days previously with no further treatment. ples, the Western blots ( Figure 5 ) were exposed for a longer time than for Figures 1 and 2 . The addition of wortmannin (3 times at 10 g per rat) starting on day 7 decreased PKB phosphorylation at 30 minutes and 6 and 12 hours later, and a decrease was also detected at 24 hours. A reduction in phospho-PKB was also noted in arteries from animals that received wortmannin (5 times at 10 g per rat) over the last 48 hours ( Figure 5 ). No change in total PKB levels was noted at any time.
Once we established that phospho-PKB levels were decreased, a similar group of animals was subjected to balloon injury, and 7 days later, wortmannin (3 times at 10 g per rat) was administered over the last 24 hours or over the last 48 hours (5 times at 10 g per rat). In both experiments, SMC replication was measured over the last 24 hours, and no significant change in intimal cell replication or in the level of cyclin D 1 was detected ( Figure 6 ).
Discussion
In a recent report, we showed that the ERK1/2 signaling pathway was activated within 30 minutes after balloon catheter injury, peaked by 6 hours, and remained slightly elevated for up to 2 days. At later times, only minimal activation, similar to that of control arteries, was observed. 1 Evidence for the importance of the ERK1/2 pathway in SMC replication was provided by the use of a MEK1 inhibitor, PD98059, which blocked phosphorylation of ERK1/2 and also inhibited medial SMC proliferation after balloon injury. 1 However, this inhibitor had no effect on intimal SMC proliferation after 7 days. Thus, we concluded that other signaling pathways play an important role in intimal SMC replication.
PI(3)K Signaling Pathway Is Activated by Balloon Injury
In the present study, we chose to examine PI(3)K because we had already noted that p70s6k, a downstream target of PI(3)K signaling, was activated by balloon catheter injury. 1 The formation of phosphatidylinositol triphosphate and phosphatidylinositol diphosphate by action of PI(3)K recruits PKB to the cell membrane and thus allows its phosphorylation by PDK 1 and PDK 2 (for a review, see References 10 and 12 to 14). Active PKB then targets a variety of substrates, including ribosomal protein S6 kinase, 15 glucose transporter 4, 16 glycogen synthase kinase 3, 17, 18 and cell survival factors. 19 Of interest to us was the strong relationship between the PI(3)K pathway and cell proliferation. [7] [8] [9] Our data show that PKB was phosphorylated within 30 minutes after balloon catheter injury and remained active for up to 48 hours. In this respect, the activation of the PI(3)K pathway followed a pattern similar to that observed for the ERK pathway. 1
Inhibition of PI(3)K Blocks Medial SMC Replication After Injury
To determine whether PI(3)K activity is necessary for SMC proliferation, we used a specific PI(3)K inhibitor, wortmannin, to block its activity. 20, 21 Incubation of an arterial segment with wortmannin significantly inhibited PKB phosphorylation and significantly decreased SMC replication while having no effect on ERK1/2 phosphorylation. However, we discontinued infusing wortmannin directly into the artery because at later times after injury, addition surgery would be required to reexpose the artery, and this activated the ERK and PI(3)K pathways. Thus, to compare the effects of wortmannin on the early and 7-day SMC replication, we opted to use an intravenous route for wortmannin administration. The administration of wortmannin intravenously also allowed us the opportunity to add multiple doses of the inhibitor if required. Two injections of 10 g wortmannin, given 1 hour apart before arterial injury, inhibited PKB phosphorylation for up to 6 hours, but by 12 hours, the levels of phosphorylated PKB levels were again elevated (data not shown). Therefore, we administered a third dose of wortmannin 11 hours after injury to ensure a more prolonged inhibition of this pathway. By use of this protocol, PKB phosphorylation was depressed for up to 24 hours, and medial SMC proliferation, measured between 24 to 48 hours, was markedly inhibited.
Wortmannin binds to and irreversibly inhibits the p110 catalytic subunit of PI(3)K, 21, 22 but there are data showing that high concentrations of wortmannin (Ͼ100-fold higher) can interfere with other signals, such as myosin light chain kinase. 22, 23 Perhaps more important is the finding that wortmannin can partially inhibit platelet-derived growth factordependent Raf1 and ERK activation in certain cells. 24 Thus, there is the possibility that wortmannin might block the ERK pathway and thus influence SMC replication. To determine whether wortmannin was acting in this way, we asked whether other signaling pathways associated with entry into the cell cycle were affected by this treatment. The administration of wortmannin had no effect on ERK1/2 phosphorylation at any time studied or on other mitogen-activated protein kinases, including c-Jun N-terminal kinase, p38, and big mitogen-activated protein kinase 1 (BMK1) (data not shown). We believe that perhaps the best evidence that intravenous wortmannin did not block other pathways necessary for SMC replication is the finding that this inhibitor had no effect on SMC replication 7 days after injury (see below). Figure 6 . A, Effect of wortmannin (W) or vehicle alone (V) on intimal SMC replication rate (BrdU index) and cell density (CD) in rat arteries at 8 and 9 days after balloon injury. The first group of animals was given wortmannin (3 times at 0 g IV per rat) between days 7 and 8 after injury; the second group received wortmannin between days 7 and 9 after injury (5 times at 10 g IV per rat). SMC replication was measured over the last 24 hours. B, Effect of wortmannin or vehicle alone on cyclin D 1 levels. Control animals (C) were not subjected to injury.
If wortmannin acted by blocking a non-PI(3)K pathway required for cell replication, then the administration of this inhibitor should have blocked replication regardless of the time after injury. This was clearly not the case.
Despite our attempts to ensure that wortmannin specifically blocked the PI(3)K pathway, we acknowledge that such chemical inhibitors could have unknown effects in vivo and that, as such, it will be important to validate this result by other means. This may not be easily accomplished. The other commonly used PI(3)K inhibitor, LY294002, is very insoluble, and we have been unable to inhibit PKB phosphorylation after injury, presumably because an effective concentration could not be achieved in the artery (data not shown). Another approach would be to infect SMCs at the time of injury with dominant-negative PKB by use of an adenoviral vector. This approach is not without problems, the major drawback being that the transgene expression declines within days after infection; this appears to be related to the extent of cell replication. 25 As such, this approach would not be suitable to determine whether inhibition of the PI(3)K pathway is important for intimal SMC replication.
How the PI(3)K regulates entry into the cell cycle is not fully understood, but recent studies suggest that this pathway is required for mitogen-induced cyclin D 1 expression. 26, 27 Cyclin D binds to and activates cdk4/6, and its expression is essential for cell cycle progression (for a review, see Reference 28). The PI(3)K pathway is also involved in stabilizing the cyclin D 1 protein. 29 Our results show that blockade of this pathway with wortmannin reduced the levels of cyclin D 1 after balloon catheter injury; however, we cannot conclude whether this was due to a decrease in transcription or a change in protein stability. However, in other studies in vitro, we have found that PI(3)K activation is necessary for cyclin D 1 transcription (data not shown).
Inhibition of PI(3)K Does Not Block Intimal SMC Replication 7 Days After Injury
When wortmannin was given to animals whose arteries had been injured with a balloon catheter 7 days previously, intimal SMC proliferation was not significantly inhibited. That wortmannin was delivered in an effective dose to these replicating cells was ascertained by the fact that the background levels of PKB phosphorylation were blocked. Why this signaling pathway is necessary for acute SMC replication but not replication at later times cannot not readily be explained. One reason for this result may lie in the difference between these 2 SMC populations with respect to their positions in the cell cycle at the time of wortmannin treatment. The proliferation induced by balloon injury between 24 and 48 hours will be synchronized. In contrast, at 7 days after injury, the intimal SMCs are likely to be proliferating asynchronously. Thus, inhibition of PI(3)K by wortmannin in asynchronously cycling cells over 24 hours may have affected only a subgroup of proliferating cells. To compensate for this possibility, we administered wortmannin every 12 hours over a 48-hour period (days 7 to 9 after injury) and measured proliferation over the final 24 hours. This treatment reduced the level of PKB phosphorylation but still had no effect on the proliferation rate of the intimal SMCs. Thus, even prolonged inhibition of PI(3)K over 48 hours does not influence the replication of intimal SMCs.
The above data suggest that PI(3)K is not necessary for the replication of SMCs after 7 days. This finding is similar to the ERK pathway, in which SMC replication can be blocked only with a MEK1 inhibitor immediately after injury and not after 7 days. 1 Presumably, therefore, other signaling pathways are important for the entry of these SMCs into S phase. Interestingly, intimal SMCs show strong expression of cyclin D 1 , and recent studies have suggested that several pathways, other than ERK1/2 and PI(3)K, may upregulate cyclin D 1 expression and thus entry into the cell cycle (for a review, see Reference 30) . These pathways include activation of Rho GTPase and Ral. 26, 31, 32 Studies are now under way to determine whether these factors play a role in cyclin D 1 expression in the growing neointima.
PI(3)K Inhibition Does Not Promote Cell Death
Inhibition of the PI(3)K pathway has been linked to apoptosis. For example, overexpression of PKB prevents apoptosis in primary neurons induced by survival factor withdrawal. 19 Further activated PI(3)K and PKB have been shown to protect canine kidney (MDCK) cells from apoptosis induced by detachment from their extracellular matrix. 33 In this experiment, wortmannin decreased SMC number 48 hours after injury, which might suggest an increase in apoptosis due to PI(3)K inhibition. In experiments using caspase-3 cleavage as a marker of apoptosis, we found no evidence of cell death until day 7 day after injury, and wortmannin did not affect this result. This finding agrees with the data of Han et al, 34 who first noted SMC apoptosis in rat arteries 9 days after balloon injury. One likely explanation for the decrease in SMC cell number seen after 48 hours of treatment is that the mechanically induced cell loss was accompanied by a decrease in cell replication caused by wortmannin. Under these conditions, a reduction in cell number 48 hours after the initial injury would be expected. In contrast, no significant change in SMC numbers was detected 8 and 9 days after injury, when wortmannin had no effect on SMC replication.
In summary, the present study shows that the PI(3)K pathway is increased for Ϸ48 hours after balloon catheter injury. The administration of wortmannin, a PI(3)K inhibitor, reduced PKB phosphorylation with a concomitant reduction in medial SMC proliferation and cyclin D 1 48 hours after balloon injury. This inhibitor did not inhibit ERK1/2 phosphorylation. Administration of wortmannin did not reduce intimal SMC proliferation despite the inhibition of PKB phosphorylation. These data suggest that PI(3)K activation is required for the early replication of medial SMCs but not for the replication of SMCs in the developing intimal lesions.
